Kevin Lundquist

Kevin Lundquist

Director of Finance/CFO at OUTLOOK THERAPEUTICS, INC.

Net worth: - $ as of 31/07/2026

59 year
Health Technology
Consumer Services
Producer Manufacturing

Profile

Kevin Lundquist is currently Chief Financial Officer, Treasurer & Secretary at Outlook Therapeutics, Inc. since 2026.
Former roles include Chief Financial Officer at CapsoVision, Inc. from 2024 to 2025; Vice President-Finance at Revance Therapeutics, Inc. from 2022 to 2023; Senior Director-Global Manufacturing Finance at Roche Consulting LLC from 2014 to 2020; Chief Financial Officer at Caterpillar Japan LLC from 2010 to 2014; Head-Finance Operations at Caterpillar India Pvt Ltd. from 2006 to 2010; Director-International Business Development at Abbott Laboratories from 2003 to 2006; and Chief Financial Officer at Abzena Ltd. Education includes an undergraduate degree from the University of Utah and an MBA from Utah State University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
13/04/2026 0 ( -.--% ) - $ 31/07/2026

Kevin Lundquist active positions

CompaniesPositionStart
OUTLOOK THERAPEUTICS, INC. Director of Finance/CFO 01/09/2026

Former positions of Kevin Lundquist

CompaniesPositionEnd
CAPSOVISION, INC. Director of Finance/CFO 27/08/2025
REVANCE THERAPEUTICS, INC. Director of Finance/CFO 01/12/2023
Corporate Officer/Principal 01/08/2020
Director of Finance/CFO 01/01/2014
Corporate Officer/Principal 01/05/2010
See the detail of Kevin Lundquist's experience

Training of Kevin Lundquist

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

66

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Producer Manufacturing

Producer Manufacturing

Health Technology

Health Technology

Commercial Services

  1. Stock Market
  2. Insiders
  3. Kevin Lundquist